IDEX Other Income (Expense) decreased by 50.0% to $600.00K in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 142.9%, from -$1.40M to $600.00K. Over 3 years (FY 2021 to FY 2024), Other Income (Expense) shows an upward trend with a -46.5% CAGR.
An increase suggests higher non-operating gains or lower non-operating costs, while a decrease indicates higher non-operating expenses or lower non-operating income.
Represents the net total of non-operating financial activities, including interest income, interest expense, foreign cur...
Standard across all public companies; peers in the medical device sector often show similar volatility due to currency fluctuations.
other_income_expense_net| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$17.20M | -$600.00K | $0.00 | $2.30M | $0.00 | $1.00M | $600.00K | $600.00K | -$8.30M | $2.10M | $0.00 | $2.70M | $0.00 | -$2.70M | $2.60M | -$1.40M | -$2.40M | $1.20M | $600.00K |
| QoQ Change | — | +96.5% | +100.0% | — | -100.0% | — | -40.0% | +0.0% | <-999% | +125.3% | -100.0% | — | -100.0% | — | +196.3% | -153.8% | -71.4% | +150.0% | -50.0% |
| YoY Change | — | — | — | — | +100.0% | +266.7% | — | -73.9% | — | +110.0% | -100.0% | +350.0% | +100.0% | -228.6% | — | -151.9% | — | +144.4% | +142.9% |